Gao Hanlin sold $17K of FLGT
Gao Hanlin (Chief Scientific Officer) sold 945 shares of Fulgent Genetics, Inc. (FLGT) at $17.60 on 2026-05-27.
How this was made
The 30-second read
Why it matters
The only new information is the insider sale details (945 shares at $17.60) and the absence of a 10b5-1 plan.
Market read
Traders may note insider selling, but the disclosure lacks fundamental drivers and is unlikely to move the stock materially on its own.
What to watch
The filing does not indicate whether other insiders sold/bought, and the transaction size is small relative to typical institutional flows.
Background
The article is a SEC Form 4 insider transaction disclosure for Fulgent Genetics, Inc.
Ticker impact
Fulgent Genetics insider Gao Hanlin sold 945 shares at $17.60 via an open-market sale, disclosed on Form 4.
Limited near-term impact; any reaction is likely sentiment-driven rather than information-driven.
Form 4 shows an officer sale (945 shares, $16,632) with no pre-arranged 10b5-1 plan, but the filing provides no new company-specific operational or financial information.
Market effects
No clear sector read-through; this is company-specific insider transaction data.
None.
None.
Counterpoint
Insider sales can be driven by diversification, taxes, or personal liquidity needs and may not signal reduced confidence.
Key entities
- issuerFulgent Genetics, Inc.
Subject of the Form 4 insider sale by its Chief Scientific Officer.
- insiderGao Hanlin
Chief Scientific Officer who sold 945 shares in an open-market transaction.
